Cytosolic lipolysis and lipophagy: two sides of the same coin
The lower doses (initiation and escalation doses) of 0.25 mg, 0.5 mg, and 1 mg are not for weight management but rather to give the body time to adjust to the medicine
I vividly remember debating the GLP-1 market size with sell-side analysts around this time, and several contested the TAM was $30-50B, even though my conservative napkin math pointed to $100B-$300B3
Aetna Prior Authorization Timeline Standard requests: 3 to 5 business days when submitted through Aetnas electronic provider portal
Excitingly, the same research group found that applying dexamethasone during KD treatment might delay cachexia onset without affecting the inhibition of tumor growth, providing fundamental insight into reversing the limitations of the clinical application of KD
The reduction of pro-inflammatory cytokines, improvement in intestinal barrier integrity, and potential modulation of gut microbiota composition represent mechanisms that could theoretically complement existing IBD therapies